Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-06-12

Clinical Trial Update: Comparison Between Methyl Prednisolone and Intravenous Dexamethazone in Severe Immune Thrombocytopenic Purpra

View source ↗

Summary

This update reports a clinical trial comparing methylprednisolone to intravenous dexamethasone for severe immune thrombocytopenia, with the trial status current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Assiut University | Conditions: Immune Thrombocytopenia | Status: UNKNOWN